结直肠癌肝转移的新辅助治疗

Neoadjuvant therapy of liver metastases form colorectal cancer

随着人们生活水平的提高以及饮食结构的改变，结直肠癌发病率呈逐年上升的趋势。约有25％的结直肠癌患者发现时即伴有肝转移。原发肿瘤联合肝转移灶一起切除能够提高患者的生存期，因此如何能够提高结直肠癌肝转移患者的手术切除率成为治疗的关键。新辅助治疗的提出为结直肠癌肝转移患者的治疗提供了新的契机。

With the development of peaple＇s life and the change of diet, the incidence rate of colorectal cancer is increasing. There are Twenty-five percent of patients were found liver metastases in the first diagosis. Surgical resection of liver metastases from colorectal cancer is known to be associated with long term survival. So it is the key to increase the resection rate for colorectal cancer patients with liver metastases. The incurruence of neoadjuvant therapy may be useful in therapy of colorectal cancer patients with liver mtastases.